Comparison Between Two Revascularization Strategies in MVD Patients With Uncomplicated ST-elevation MI
NCT ID: NCT04582175
Last Updated: 2020-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2020-07-01
2020-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In-hospital Versus After-discharge Complete Revascularization
NCT04743154
Impact of Ischemic Post-conditioning
NCT04068116
Timing of Complete Revascularization for Multivessel Coronary Artery Disease in STEMI
NCT02756000
Strategies of Revascularization in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Disease
NCT01179126
Revascularization Versus Optimal Medical Therapy of Chronic Total Coronary Occlusions on Left Ventricular Ischemia Reduction
NCT03756870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group A
patients who received complete revascularization by angioplasty during the PPCI
angioplasty
angioplasty of all non-culprit lesions
Group B
patients who underwent complete revascularization by angioplasty in a staged procedure
angioplasty
angioplasty of all non-culprit lesions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
angioplasty
angioplasty of all non-culprit lesions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Multi-vessel disease defined as at least 1 additional non-infarct related coronary artery lesion that is at least 2.5 mm in diameter that has not been stented as part of the primary PCI and that is amenable to successful treatment with PCI and has:
* At least 75% diameter stenosis (visual estimation) or
* At least 50% diameter stenosis (visual estimation) with fractional flow reserve (FFR) ≤ 0.80
3. Age between 18 and 90 years
4. Written informed consent could be obtained from all the patients
Exclusion Criteria
2. Cardiogenic shock
3. Non-cardiovascular known co-morbidity reducing life expectancy to \< 2 years
4. Any factor precluding 1year follow-up
5. Prior Coronary Artery Bypass Graft (CABG) Surgery
6. A different operator from the previously designated
7. Unable to provide consent for any other reason
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oradea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nichita-Brendea Mihnea-Traian
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mihnea-Traian T Nichita-Brendea, MD
Role: PRINCIPAL_INVESTIGATOR
Spitalul Clinic Judetean de Urgenta Oradea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spitalul Clinic Judetean de Urgenta Oradea
Oradea, Bihor County, Romania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Uoradea
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.